SCHEMBL21881902

SCHEMBL21881902

CP(C)(=O)c1cccc(-c2c3ccccc3c(-c3ccc(-c4nc(-c5ccccc5)nc(-c5ccccc5)n4)cc3)c3ccccc23)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 1/20 0.39
MEN1 O00255 8/20 0.37
KMT2A Q03164 8/20 0.37
MAPT P10636 8/20 0.37
ALDH1A1 P00352 6/20 0.37
HPGD P15428 6/20 0.37
KDM4E B2RXH2 3/20 0.37
NPSR1 Q6W5P4 3/20 0.37
RXFP1 Q9HBX9 1/20 0.37
CYP2C19 P33261 1/20 0.37
LMNA P02545 2/20 0.36
ATM Q13315 1/20 0.36
GLA P06280 1/20 0.36
ESR1 P03372 3/20 0.36
ESR2 Q92731 2/20 0.36
NTSR1 P30989 1/20 0.34
ABCG2 Q9UNQ0 4/20 0.34
GAA P10253 1/20 0.34
ADORA3 P0DMS8 1/20 0.34
ABCB1 P08183 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24226052 0.94 L3MBTL1 (0.37) L3MBTL1MEN1KMT2AALDH1A1HPGD
SCHEMBL21881776 0.94 L3MBTL1 (0.39) L3MBTL1MEN1KMT2AMAPTALDH1A1
SCHEMBL21803702 0.94 L3MBTL1 (0.39) L3MBTL1MEN1KMT2AMAPTALDH1A1
SCHEMBL21881920 0.93 MEN1 (0.46) L3MBTL1MEN1KMT2AMAPTALDH1A1
SCHEMBL21881914 0.93 L3MBTL1 (0.38) L3MBTL1MEN1KMT2AMAPTALDH1A1
SCHEMBL20565711 0.90 L3MBTL1 (0.38) L3MBTL1MEN1KMT2AMAPTALDH1A1
SCHEMBL18893073 0.90 ACHE (0.37) MAPTLMNAESR1ESR2HTT
SCHEMBL22019488 0.89 ACHE (0.35) ESR1ESR2
SCHEMBL21881915 0.89 L3MBTL1 (0.37) L3MBTL1MEN1KMT2AMAPTALDH1A1
SCHEMBL21881921 0.89 MEN1 (0.51) MEN1KMT2AMAPTALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11795186-B2 Organic electronic device comprising an organic semiconductor layer and a device NOVALED GMBH (DE) 2023-10-24 US disclosed
US-11795186-B2 Organic electronic device comprising an organic semiconductor layer and a device NOVALED GMBH (DE) 2023-10-24 US disclosed
US-20200095269-A1 Organic Electronic Device Comprising an Organic Semiconductor Layer and a Device NOVALED GMBH (DE) 2020-03-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200095269-A1 Organic Electronic Device Comprising an Organic Semiconductor Layer and a Device C1S, C1R, CCNA1 L3MBTL1 812/4885MEN1 762/4885KMT2A 3297/4885
US-11795186-B2 Organic electronic device comprising an organic semiconductor layer and a device C1S, C1R, CCNA1 L3MBTL1 812/4885MEN1 762/4885KMT2A 3297/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.